Vaxcyte, Inc.
PCVX
$54.58
-$1.63-2.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.82% | -27.77% | -18.37% | -2.65% | -32.93% |
| Total Depreciation and Amortization | 88.57% | 4.17% | 2.36% | 1.86% | 6.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.09% | 379.46% | -64.75% | -18.37% | 168.45% |
| Change in Net Operating Assets | -161.43% | -4.80% | 168.04% | -1,892.56% | -108.51% |
| Cash from Operations | -56.89% | -18.27% | 27.13% | -49.26% | -83.50% |
| Capital Expenditure | 30.09% | -23.49% | 63.53% | 10.91% | 21.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.26% | 52.25% | -41.70% | 128.47% | 40.03% |
| Cash from Investing | -4.99% | 55.86% | -36.96% | 122.13% | 39.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,016.01% | -90.54% | -46.52% | 0.95% | -99.61% |
| Repurchase of Common Stock | 74.68% | 33.79% | -- | -- | 88.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | 165.60% | -245.79% | 231.75% | -84.53% | -99.68% |
| Foreign Exchange rate Adjustments | -39.52% | -63.63% | -31.74% | -13.19% | 124.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -319.84% | 36.38% | 2.24% | 93.81% | -224.56% |